Zobrazeno 1 - 10
of 103
pro vyhledávání: '"R. Keith Campbell"'
Autor:
R. Keith Campbell
Publikováno v:
Hospital Pharmacy. 46:580-590
This article presents strategies on how to meet the challenges presented by the use of insulin in the hospital setting and describes trends seen in current hospital practice. Insulin provides the greatest flexibility in the hospital setting to achiev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::576332ba37838fd6f4f80ae8d775413a
https://doi.org/10.1310/hpj4608-580
https://doi.org/10.1310/hpj4608-580
Autor:
R. Keith Campbell, Luigi Brunetti
Publikováno v:
Journal of Pharmacy Practice. 24:417-425
Purpose: The clinical experience and role in therapy of colesevelam in type 2 diabetes mellitus (T2DM) is discussed. Summary: Colesevelam HCl is a bile acid sequestrant (BAS) with proven efficacy in reducing elevated low-density lipoprotein cholester
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd77346573f104cec2419da25a5e9bc5
https://doi.org/10.1177/0897190011406125
https://doi.org/10.1177/0897190011406125
Autor:
R. Keith Campbell, Teresa M. Martin
Publikováno v:
Diabetes Spectrum. 24:113-118
Renewed interest in vitamin D, the so-called “sunshine vitamin,” has occurred recently because it has been linked to everything from cancer and heart disease to diabetes.1 Research studies continue to pour into the literature stating that vitamin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51b9fd8637024259e88c1e8af290d1dc
https://doi.org/10.2337/diaspect.24.2.113
https://doi.org/10.2337/diaspect.24.2.113
Autor:
Joshua J. Neumiller, R Keith Campbell
Publikováno v:
American Journal of Health-System Pharmacy. 67:1515-1525
Purpose The pharmacology, pharmacokinetics, efficacy, safety, and dosage and administration of saxagliptin are reviewed. Summary Saxagliptin is a selective, reversible inhibitor of dipeptidyl peptidase-4 (DPP-4) approved for the treatment of type 2 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::387373540f94ac3089e7fe15ef88e55a
https://doi.org/10.2146/ajhp090555
https://doi.org/10.2146/ajhp090555
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 3:215-226
Liraglutide is a glucagon-like peptide-1 analog with pharmacokinetic properties suitable for once-daily administration approved by the Food and Drug Administration for the treatment of patients with type 2 diabetes. Clinical trial data from large, co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6535cb2604a45735d3ac64dcc7431782
https://doi.org/10.2147/dmso.s7314
https://doi.org/10.2147/dmso.s7314
Publikováno v:
Annals of Pharmacotherapy. 44:1231-1239
Objective: To review the pharmacology, pharmacokinetics, efficacy, safety, and clinical use of Technosphere insulin. Data Sources: A MEDLINE search (1966–March 2010) was conducted for English-language articles using the terms AFREZZA, AFRESA, Techn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ff896a329b5334b2b8cffa1f283b76
https://doi.org/10.1345/aph.1p055
https://doi.org/10.1345/aph.1p055
Autor:
David L. Tetrick, Patricia Geil, Christopher G. Parkin, R. Keith Campbell, Deborah Hinnen, William H. Polonsky
Publikováno v:
The Diabetes Educator. 35:915-927
PurposeThe purpose of this article is to discuss practical approaches to the use of self-monitoring of blood glucose (SMBG) in clinical practice using paired glucose testing. A rationale for SMBG use and innovative tools for data collection and analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f30a50f42068ecafc00f361b46733229
https://doi.org/10.1177/0145721709347601
https://doi.org/10.1177/0145721709347601
Autor:
Sara Miller, R. Keith Campbell
Publikováno v:
The Diabetes Educator. 35:731-747
PURPOSE More than 24 million adults and children in the United States are living with diabetes, and the vast majority of those individuals have type 2 diabetes. The clinical benefits of good glycemic control have been well established. Most patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d311c2f6e888b0d6e35b9b1df9d922
https://doi.org/10.1177/0145721709342900
https://doi.org/10.1177/0145721709342900
Autor:
R. Keith Campbell
Publikováno v:
Journal of the American Pharmacists Association. 49:S10-S15
Objective To describe the progression of beta-cell dysfunction, now presumed to be the primary progenitor of type 2 diabetes, which appears early in the clinical course (perhaps antedating and even contributing to the development of insulin resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9762bd45fc41d997cc431305e4a58c3a
https://doi.org/10.1331/japha.2009.09076
https://doi.org/10.1331/japha.2009.09076
Autor:
R. Keith Campbell
Publikováno v:
Journal of the American Pharmacists Association. 49:S3-S9
Objective To provide an overview of the disease burden and current strategies in the treatment of patients with type 2 diabetes. Data sources Medline search of all relevant clinical and review articles. Study selection By the author. Data extraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e55e0b3be9dcee7709d290c606bcca0
https://doi.org/10.1331/japha.2009.09077
https://doi.org/10.1331/japha.2009.09077